eCite Digital Repository

Items where Subject is Socio-Economic Objective, Health, Health and Support Services, Health Policy Economic Outcomes

Journal Article
Wang, L and Si, L and Cocker, F and Palmer, AJ and Sanderson, K, A systematic review of cost-of-illness studies of multimorbidity, Applied Health Economics and Health Policy, 16, (1) pp. 15-29. ISSN 1175-5652 (2018) [Refereed Article] 
Wang, L and Cocker, F and Kilpatrick, M and Otahal, P and Si, L and Palmer, AJ and Sanderson, K, The associations of multimorbidity with health-related productivity loss in a large and diverse public sector setting: A cross-sectional survey, Journal of Occupational and Environmental Medicine, 60, (6) pp. 528-535. ISSN 1076-2752 (2018) [Refereed Article] 
Melody, SM and Martin-Gall, V and Harding, B and Veitch, MGK, The retail availability of tobacco in Tasmania: evidence for a socio-economic and geographical gradient, Medical Journal of Australia, 208, (5) pp. 205-208. ISSN 0025-729X (2018) [Refereed Article] 
Cocker, F and Sanderson, K and LaMontagne, AD, Estimating the economic benefits of eliminating job strain as a risk factor for depression, Journal of Occupational and Environmental Medicine, 59, (1) pp. 12-17. ISSN 1076-2752 (2017) [Refereed Article] 
Si, L and Chen, M and Palmer, AJ, Has equity in government subsidy on healthcare improved in China? Evidence from the China's National Health Services Survey, International Journal for Equity in Health, 16, (1) Article 6. ISSN 1475-9276 (2017) [Refereed Article]
Chen, M and Palmer, AJ and Si, L, Improving equity in health care financing in China during the progression towards Universal Health Coverage, BMC Health Services Research, 17, (1) Article 852. ISSN 1472-6963 (2017) [Refereed Article]
Wang, L and Palmer, AJ and Cocker, F and Sanderson, K, Multimorbidity and health-related quality of life (HRQoL) in a nationally representative population sample: implications of count versus cluster method for defining multimorbidity on HRQoL, Health and Quality of Life Outcomes, 15, (1) Article 7. ISSN 1477-7525 (2017) [Refereed Article]
Chen, M and Palmer, AJ and Si, L, Assessing equity in benefit distribution of government health subsidy in 2012 across East China: benefit incidence analysis, International Journal for Equity in Health, 15 Article 15. ISSN 1475-9276 (2016) [Refereed Article]
Chen, M and Si, L and Winzenberg, TM and Gu, J and Jiang, Q and Palmer, AJ, Cost-effectiveness of raloxifene in the treatment of osteoporosis in Chinese postmenopausal women: impact of medication persistence and adherence, Patient Preference and Adherence, 10 pp. 415-423. ISSN 1177-889X (2016) [Refereed Article]
Annear, MJ and Tierney, LT and Vickers, JC and Palmer, AJ, Counting the cost of dementia-related hospital admissions: a regional investigation, Australasian Journal on Ageing, 35, (3) pp. E32-E35. ISSN 1440-6381 (2016) [Refereed Article] 
Zaidi, STR, De-mystifying pharmacoeconomics and a suggestive approach to evaluating the cost-effectiveness of antimicrobial stewardship, Journal of Pharmacy Practice and Research, 46 pp. 1-6. ISSN 1445-937X (2016) [Refereed Article] 
Campbell, JA and Venn, A and Neil, A and Hensher, M and Sharman, M and Palmer, AJ, Diverse approaches to the health economic evaluation of bariatric surgery: a comprehensive systematic review, Obesity Reviews, 17, (9) pp. 850-894. ISSN 1467-7881 (2016) [Refereed Article] 
Lee, KS and Khan, TM and Ming, LC, Impact of Trans-Pacific Partnership Agreement on cost of medicine, Research in Social and Administrative Pharmacy ISSN 1934-8150 (2016) [Letter or Note in Journal]
Lee, KS and Khan, TM and Ming, LC, Review of data exclusivity provisions in the Trans-Pacific Partnership agreement, Research in Social and Administrative Pharmacy, 12, (4) pp. 545-547. ISSN 1934-8150 (2016) [Letter or Note in Journal]
Neil, AL and Nelson, M and Palmer, AJ, The new Australian after-hours general practice incentive payment mechanism: equity for rural general practice?, Health Policy, 120, (7) pp. 809-817. ISSN 0168-8510 (2016) [Refereed Article]
Khan, TM and Wong, PL and Ming, LC, Towards A Sustainable Dispensing Separation Model, Research in Social and Administrative Pharmacy ISSN 1934-8150 (2016) [Letter or Note in Journal]
Salahudeen, MS and Duffull, SB and Nishtala, PS, Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review, BMC geriatrics, 15 pp. 1-14. ISSN 1471-2318 (2015) [Refereed Article]
Baxter, S and Campbell, S and Sanderson, K and Cazaly, C and Venn, A and Owen, C and Palmer, AJ, Development of the Workplace Health Savings Calculator: a practical tool to measure economic impact from reduced absenteeism and staff turnover in workplace health promotion, BMC Research Notes, 8 Article 457. ISSN 1756-0500 (2015) [Refereed Article]
Neil, AL and Nelson, MR and Richardson, T and Mann-Leonard, M and Palmer, AJ, General practice after-hours incentive funding: a rationale for change, Medical Journal of Australia, 203, (2) pp. 82-85. ISSN 0025-729X (2015) [Refereed Article] 
Palmer, AJ and Si, L and Gordon, JM and Saul, T and Otahal, P and Hitchens, PL, Investigating the costs of major and minor cycling crashes in Tasmania, Australia, Australian and New Zealand Journal of Public Health, 39, (5) pp. 485-490. ISSN 1753-6405 (2015) [Refereed Article] 
Salahudeen, MS and Duffull, B and Nishtala, PS, Impact of Anticholinergic Discontinuation on Cognitive Outcomes in Older People: A Systematic Review, Drugs & Aging, 31, (3) pp. 185-192. ISSN 1170-229X (2014) [Refereed Article] 
Baxter, S and Sanderson, K and Venn, AJ and Blizzard, CL and Palmer, AJ, The relationship between return on investment and quality of study methodology in workplace health promotion programs, American Journal of Health Promotion, 28, (6) pp. 347-363. ISSN 0890-1171 (2014) [Refereed Article] 
Cooper, MS and Palmer, AJ and Seibel, MJ, Cost-effectiveness of the Concord Minimal Trauma Fracture Liaison service, a prospective, controlled fracture prevention study, Osteoporosis International, 23, (1) pp. 97-107. ISSN 1433-2965 (2012) [Refereed Article]
Ferguson, SG and Allen, J and Kronfeld, N, Education about NRT safety overcomes smokers' cost barrier - study, The Tan Sheet, 19, (32) pp. 1, 4-5. ISSN 1530-1206 (2011) [Letter or Note in Journal]
Valentine, WJ and Palmer, AJ and Lammert, M and Langer, J and Brandle, M, Evaluating the Long-Term Cost-Effectiveness of Liraglutide Versus Exenatide BID in Patients With Type 2 Diabetes Who Fail to Improve With Oral Antidiabetic Agents, Clinical Therapeutics: The International, Peer-Reviewed Journal of Drug Therapy, 33, (11) pp. 1698-1712. ISSN 0149-2918 (2011) [Refereed Article]
Williams, S, On islands, insularity, and opium poppies: Australia's secret pharmacy, Environment and Planning D: Society and Space, 28, (2) pp. 290-310. ISSN 0263-7758 (2010) [Refereed Article]
Brownscombe, PG, How many clinical interventions should occur - an economist's perspective, Australian Pharmacist, 28, (7) pp. 610 - 611. ISSN 0728-4632 (2009) [Letter or Note in Journal]
Valentine, WJ and Tucker, D and Palmer, AJ and Minshall, ME and Foos, V and Silberman, C, PROactive Study Group, Long-Term Cost-Effectiveness of Pioglitazone versus Placebo in Addition to Existing Diabetes Treatment: A US Analysis Based on PROactive, Value in Health, 12, (1) pp. 1-9. ISSN 1098-3015 (2009) [Refereed Article] 
Prajogo, J and Neil, A and Duke, J and Zhang, H and Stokes, B and Rowlings, P, Modelling cost-effectiveness of high-dose chemotherapy as treatment for relapsed aggressive non-Hodgkin lymphoma in an Australian setting, Internal Medicine Journal, 39, (8) pp. 519-526. ISSN 1444-0903 (2009) [Refereed Article] 
Thompson, AJ, Over-the-counter orlistat: an alli for whom? Patients or profit makers?, The Pharmaceutical Journal , 282 pp. 511. ISSN 0031-6873 (2009) [Letter or Note in Journal]
Thompson, AJ, The case for doxycycline, Prescriber, 19, (Nov) pp. 43. ISSN 0959-6682 (2009) [Letter or Note in Journal]
Brownscombe, PG, The pharmacist's duty to document issues relating to clinical interventions that respond to drug-related problems, Australian Pharmacist, 28, (10) pp. 897-899. ISSN 0728-4632 (2009) [Letter or Note in Journal]
Palmer, AJ and Valentine, WJ and Chen, R and Mehin, N and Gabriel, S and Bregman, B and Rodby, RA, A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA, Nephrology, Dialysis and Transplantation, 23, (4) pp. 1216-1223. ISSN 0931-0509 (2008) [Refereed Article] 
Kinsman, LD and Champion, R and Lee, G and Martin, M and Masman, K and May, E and Mills, T and Taylor, MD and Thomas, P and Williams, RJ and Zalstein, S, Assessing the impact of streaming in a regional emergency department, Emergency Medicine Australasia (Print), 20 pp. 221-227. ISSN 1742-6731 (2008) [Refereed Article] 
Goodall, G and Jendle, JH and Valentine, WJ and Munro, V and Brandt, AB and Ray, JA and Roze, S and Foos, V and Palmer, AJ, Biphasic insulin aspart 70/30 vs. insulin glargine in insulin naive type 2 diabetes patients: modelling the long-term health economic implications in a Swedish setting, International Journal of Clinical Practice, 62, (6) pp. 869-876. ISSN 1368-5031 (2008) [Refereed Article] 
Chirakup, S and Chaiyakunapruk, N and Chaikledkeaw, U and Pongcharoensuk, P and Ongphiphadhanakul, B and Roze, S and Valentine, WJ and Palmer, AJ, Cost-effectiveness analysis of thiazolidinediones in uncontrolled type 2 diabetic patients receiving sulfonylureas and metformin in Thailand, Value in Health, 11, (Supplement 1) pp. S43-S51. ISSN 1098-3015 (2008) [Refereed Article] 
Ray, JA and Borker, R and Barber, B and Valentine, WJ and Belozeroff, V and Palmer, AJ, Cost-Effectiveness of Early versus Late Cinacalcet Treatment in Addition to Standard Care for Secondary Renal Hyperparathyroidism in the USA, Value in Health, 11, (5) pp. 800-808. ISSN 1098-3015 (2008) [Refereed Article] 
Palmer, JL and Goodall, G and Nielsen, S and Kotchie, RW and Valentine, WJ and Palmer, AJ and Roze, S, Cost-effectiveness of insulin aspart versus human soluble insulin in type 2 diabetes in four European countries: subgroup analyses from the PREDICTIVE study, Current Medical Research and Opinion, 24, (5) pp. 1417-1428 . ISSN 0300-7995 (2008) [Refereed Article] 
Gaede, P and Valentine, WJ and Palmer, AJ and Tucker, DMD and Lammert, M and Parving, HH and Pedersen, O, Cost-effectiveness of Intensified versus conventional multifactorial intervention in type 2 diabetes: Results and projections from the Steno-2 study, Diabetes Care, 31, (8) pp. 1510-1515. ISSN 0149-5992 (2008) [Refereed Article] 
Minshall, ME and Oglesby, AK and Wintle, ME and Valentine, WJ and Roze, S and Palmer, AJ, Estimating the long-term cost-effectiveness of exenatide in the United States: an adjunctive treatment for type 2 diabetes mellitus, Value in Health, 11, (1) pp. 22-33. ISSN 1098-3015 (2008) [Refereed Article] 
Valentine, WJ and Goodall, G and Aagren, M and Nielsen, S and Palmer, AJ and Erny-Albrecht, K, Evaluating the cost-effectiveness of therapy conversion to insulin detemir in patients with type 2 diabetes in Germany: a modelling study of long-term clinical and cost outcomes, Advances in Therapy: The International Journal of Drug, Device and Diagnostic Research, 25, (6) pp. 567-584. ISSN 0741-238X (2008) [Refereed Article] 
Palmer, AJ and Lammert, M and Hermansen, K, Health economic consequences of insulin analogues in the treatment of type 1 diabetes in Denmark, Ugeskrift for Laeger , 170, (15) pp. 1250-1254. ISSN 1603-6824 (2008) [Refereed Article] 
Annemans, L and Demarteau, N and Hu, SL and Lee, TJ and Morad, Z and Supaporn, T and Yang, WC and Palmer, AJ, An Asian Regional Analysis of Cost-Effectiveness of Early Irbesartan Treatment versus Conventional Antihypertensive, Late Amlodipine, and Late Irbesartan Treatments in Patients with Type 2 Diabetes, Hypertension, and Nephropathy, Value in Health, 11, (3) pp. 354-364. ISSN 1098-3015 (2007) [Refereed Article] 
Palmer, AJ and Valentine, WJ and Ray, JA and Foos, V and Lurati, F and Smith, I and Lammert, M and Roze, S, An economic assessment of analogue basal-bolus insulin versus human basal-bolus insulin in subjects with type 1 diabetes in the UK, Current Medical Research and Opinion, 23, (4) pp. 895-901. ISSN 0300-7995 (2007) [Refereed Article] 
Palmer, AJ and Roze, S and Valentine, WJ and McEwan, P and Gillett, M and Holmes, M and Clarke, P and Stevens, R and Gray, AM and Coleman, R and Sorensen, S and Muller, E and Walzer, S and Eddy, DM and Kahn, R and Bagust, A and Brown, J and Brennan, A and Chan, W and Russell, A and Hoerger, T and Hicks, K and Casciano, R and Bergemann, R, Mt Hood 4 Modelling Group , Computer modeling of diabetes and its complications - A report on the Fourth Mount Hood Challenge Meeting, Diabetes Care, 30, (6) pp. 1638-1646. ISSN 0149-5992 (2007) [Refereed Article] 
Cohen, N and Minshall, ME and Sharon-Nash, L and Zakrzewska, K and Valentine, WJ and Palmer, AJ, Continuous Subcutaneous Insulin Infusion versus Multiple Daily Injections of Insulin: Economic Comparison in Adult and Adolescent Type 1 Diabetes Mellitus in Australia, Pharmacoeconomics, 25, (10) pp. 881-897. ISSN 1170-7690 (2007) [Refereed Article] 
Gilmer, TP and Roze, S and Valentine, WJ and Emy-Albrecht, K and Ray, JA and Cobden, D and Nicklasson, L and Philis-Tsimikas, A and Palmer, AJ, Cost-effectiveness of diabetes case management for low-income populations, Health Services Research, 42, (5) pp. 1943-1959. ISSN 0017-9124 (2007) [Refereed Article] 
Coyle, D and Rodby, R and Soroka, S and Levin, A and Muirhead, N and de Cotret, PR and Chen, R and Palmer, AJ, Cost-effectiveness of irbesartan 300 mg given early versus late in patients with hypertension and a history of type 2 diabetes and renal disease: a Canadian perspective, Clinical Therapeutics: The International, Peer-Reviewed Journal of Drug Therapy, 29, (7) pp. 1508-1523. ISSN 0149-2918 (2007) [Refereed Article] 
Ray, JA and Valentine, WJ and Palmer, AJ, Cost-utility analysis of cinacalcet in addition to standard of care in the UK, Nephrology, Dialysis and Transplantation, 22, (11) pp. 3355-3357. ISSN 0931-0509 (2007) [Refereed Article] 
Ray, JA and Boye, KS and Yurgin, N and Valentine, WJ and Roze, S and McKendrick, J and Tucker, DMD and Foos, V and Palmer, AJ, Exenatide versus insulin glargine in patients with type 2 diabetes in the UK: a model of long-term clinical and cost outcomes, Current Medical Research and Opinion, 23, (3) pp. 609-622. ISSN 0300-7995 (2007) [Refereed Article] 
Palmer, AJ and Valentine, WJ and Ray, JA and Roze, S and Muszbek, N, Health economic implications of irbesartan treatment versus standard blood pressure control in patients with type 2 diabetes, hypertension and renal disease: a Hungarian analysis, The European Journal of Health Economics, 8, (2) pp. 161-168. ISSN 1618-7598 (2007) [Refereed Article] 
Ray, JA and Valentine, WJ and Roze, S and Nicklasson, L and Cobden, D and Raskin, P and Garber, A and Palmer, AJ, Insulin therapy in type 2 diabetes patients failing oral agents: cost-effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the US, Diabetes Obesity & Metabolism, 9, (1) pp. 103-113. ISSN 1462-8902 (2007) [Refereed Article] 
Alberti, KGMM and Zimmet, P and Shaw, J and Unwin, N and Orchard, T and Mbanya, JC and Sadikot, S and Pan, CY and Astrup, A and Schmidt, M and Ross, R and Grundy, S and Chan, J and Palmer, AJ and Horton, E and Herman, WH and Laakso, M and Phillip, M and Tuomilehto, J and Standl, E, IDF Consensus Meeting Faculty, International Diabetes Federation: a consensus on Type 2 diabetes prevention, Diabetic Medicine, 24, (5) pp. 451-463. ISSN 0742-3071 (2007) [Refereed Article] 
Palmer, AJ and Valentine, WJ and Ray, JA, Irbesartan treatment of patients with type 2 diabetes, hypertension and renal disease: a UK health economics analysis, International Journal of Clinical Practice, 61, (10) pp. 1626-1633. ISSN 1368-5031 (2007) [Refereed Article] 
Valentine, WJ and Bottomley, JM and Palmer, AJ and Brandle, M and Foos, V and Williams, R and Dormandy, JA and Yates, J and Tan, MH and Massi-Benedetti, M, PROactive Study Group, PROactive 06: cost-effectiveness of pioglitazone in Type 2 diabetes in the UK, Diabetic Medicine, 24, (9) pp. 982-1002. ISSN 0742-3071 (2007) [Refereed Article] 
Erny-Albrecht, K and Valentine, WJ and Christensen, J and Vestenbaek, U and Palmer, AJ, Sublingual Immunotherapy in Allergic Rhinitis and Asthma: A Review of Recent Clinical Evidence, Journal of Applied Research: in Clinical and Experimental Therapeutics, 7, (1) pp. 17-31. ISSN 1537-064X (2007) [Refereed Article] 
Valentine, WJ and Erny-Albrecht, KM and Ray, JA and Roze, S and Cobden, D and Palmer, AJ, Therapy conversion to insulin detemir among patients with type 2 diabetes treated with oral agents: a modeling study of cost-effectiveness in the United States, Advances in Therapy: The International Journal of Drug, Device and Diagnostic Research, 24, (2) pp. 273-290. ISSN 0741-238X (2007) [Refereed Article] 
Palmer, AJ and Valentine, WJ and Tucker, DMD and Ray, JA and Roze, S and Annemans, L and Lapuerta, P and Chen, R and Gabriel, S and Carita, P and Rodby, RA and de Zeeuw, D and Parving, HH and Laville, M, A French cost-consequence analysis of the renoprotective benefits of irbesartan in patients with type 2 diabetes and hypertension, Current Medical Research and Opinion, 22, (11) pp. 2095-2100. ISSN 0300-7995 (2006) [Refereed Article] 
Roze, S and Liens, D and Palmer, AJ and Berger, W and Tucker, D and Renaudin, C, A health economic model to determine the long-term costs and clinical outcomes of raising low HDL-cholesterol in the prevention of coronary heart disease, Current Medical Research and Opinion, 22, (12) pp. 2549-2556. ISSN 0300-7995 (2006) [Refereed Article] 
Roze, S and Valentine, WJ and Evers, T and Palmer, AJ, Acarbose in addition to existing treatments in patients with type 2 diabetes: health economic analysis in a German setting, Current Medical Research and Opinion, 22, (7) pp. 1415-1424. ISSN 0300-7995 (2006) [Refereed Article] 
Palmer, AJ and Roze, S and Rodby, RA and Valentine, WJ and Ritz, E and Lehnert, H, Clinical and health economic implications of early treatment with irbesartan of patients with type 2 diabetes mellitus, hypertension and nephropathy, Deutsche Medizinische Wochenschrift, 131, (31-32) pp. 1721-1726. ISSN 0012-0472 (2006) [Refereed Article] 
Currie, CJ and McEwan, P and Poole, C and Valentine, WJ and Palmer, AJ and Lammert, M and Nicklasson, L and Foos, V and Roze, S, Comments on Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin-naive type 2 diabetes patients: cost-effectiveness analysis in the UK setting, Current Medical Research and Opinion, 22, (5) pp. 967-969. ISSN 0300-7995 (2006) [Letter or Note in Journal] 
Palmer, AJ and Chen, R and Valentine, WJ and Roze, S and Bregman, B and Mehin, N and Gabriel, S, Cost-consequence analysis in a French setting of screening and optimal treatment of nephropathy in hypertensive patients with type 2 diabetes, Diabetes & Metabolism, 32, (1) pp. 69-76. ISSN 1262-3636 (2006) [Refereed Article] 
Valentine, WJ and Palmer, AJ and Erny-Albrecht, KM and Ray, JA and Cobden, D and Foos, V and Lurati, FM and Roze, S, Cost-effectiveness of basal insulin from a US health system perspective: Comparative analyses of detemir, glargine, and NPH, Advances in Therapy: The International Journal of Drug, Device and Diagnostic Research, 23, (2) pp. 191-207. ISSN 0741-238X (2006) [Refereed Article] 
Roze, S and Valentine, WJ and Zakrzewska, K and Palmer, AJ, Cost-effectiveness of CSII - Response (Response to the letter by Philip Home), Diabetic Medicine, 23, (6) pp. 707-708. ISSN 0742-3071 (2006) [Letter or Note in Journal] 
Palmer, AJ and Dinneen, S and Gavin, JR and Gray, A and Herman, WH and Karter, AJ, Cost-utility analysis in a UK setting of self-monitoring of blood glucose in patients with type 2 diabetes, Current Medical Research and Opinion, 22, (5) pp. 861-872. ISSN 0300-7995 (2006) [Refereed Article] 
Tucker, DMD and Palmer, AJ and Valentine, WJ and Roze, S and Ray, JA, Counting the costs of overweight and obesity: modeling clinical and cost outcomes, Current Medical Research and Opinion, 22, (3) pp. 575-586. ISSN 0300-7995 (2006) [Refereed Article] 
Frei, A and Palmer, AJ and Burnier, M and Hess, B, Health economic consequences of the use of irbesartan in patients with type 2 diabetes, hypertension and nephropathy in Switzerland, Praxis: Schweizerische Rundschau fuer Medizin , 95, (11) pp. 401-408. ISSN 1661-8157 (2006) [Refereed Article] 
Palmer, AJ and Roze, S and Valentine, WJ and Ray, JA and Frei, A and Burnier, M and Hess, B and Spinas, GA and Brandle, M, Health economic implications of irbesartan plus conventional antihypertensive medications versus conventional blood pressure control alone in patients with type 2 diabetes, hypertension, and renal disease in Switzerland, Swiss Medical Weekly, 136, (21-22) pp. 346-352. ISSN 1424-7860 (2006) [Refereed Article] 
Valentine, WJ and Palmer, AJ and Nicklasson, L and Cobden, D and Roze, S, Improving life expectancy and decreasing the incidence of complications associated with type 2 diabetes: a modelling study of HbA1c targets, International Journal of Clinical Practice, 60, (9) pp. 1138-1145. ISSN 1368-5031 (2006) [Refereed Article] 
Palmer, AJ and Currie, CJ, Modelling lifetime metabolic progression and cost effectiveness of treatment strategies for type 2 diabetes, Pharmacoeconomics, 24, (9) pp. 927-929. ISSN 1170-7690 (2006) [Contribution to Refereed Journal]
Bottomley, J and Palmer, AJ and Williams, R and Dormandy, J and Massi-Benedetti, M, PROactive 03: Pioglitazone, type 2 diabetes and reducing macrovascular events - economic implications?, British Journal of Diabetes and Vascular Disease , 6, (2) pp. 63-70. ISSN 1474-6514 (2006) [Refereed Article] 
Poldrugo, F and Haeger, DA and Comte, S and Walburg, J and Palmer, AJ, A critical review of pharmacoeconomic studies of acamprosate, Alcohol and Alcoholism, 40, (5) pp. 422-430. ISSN 0735-0414 (2005) [Refereed Article] 
Palmer, AJ and Tucker, DMD and Valentine, WJ and Roze, S and Gabriel, S and Cordonnier, DJ, Cost-effectiveness of irbesartan in diabetic nephropathy: a systematic review of published studies, Nephrology, Dialysis and Transplantation, 20, (6) pp. 1103-1109. ISSN 0931-0509 (2005) [Refereed Article] 
Palmer, AJ, Health economics--what the nephrologist should know, Nephrology, Dialysis and Transplantation, 20, (6) pp. 1038-1041. ISSN 0931-0509 (2005) [Contribution to Refereed Journal] 
Roze, S and Valentine, WJ and Zakrzewska, KE and Palmer, AJ, Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK, Diabetic Medicine, 22, (9) pp. 1239-1245. ISSN 0742-3071 (2005) [Refereed Article] 
Palmer, AJ and Tucker, DMD and Ray, JA and Valentine, WJ and Currie, C and McEwan, P and Brandle, M, Insulin pumps: more consultation was needed, BMJ, 331, (7521) pp. 905-906. ISSN 0959-8146 (2005) [Letter or Note in Journal] 
Palmer, AJ and Annemans, L and Roze, S and Lapuerta, P and Chen, R and Gabriel, S and Carita, P and Rodby, RA and de Zeeuw, D and Parving, HH and De Alvaro, F, Irbesartan is projected to be cost and life saving in a Spanish setting for treatment of patients with type 2 diabetes, hypertension, and microalbuminuria, Kidney International, 67, (Supplement 93) pp. S52-S54 . ISSN 0085-2538 (2005) [Refereed Article] 
Valentine, WJ and Palmer, AJ and Lammert, M and Nicklasson, L and Foos, V and Roze, S, Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin naive type 2 diabetes patients: cost-effectiveness analysis in the UK setting, Current Medical Research and Opinion, 21, (12) pp. 2063-2071. ISSN 0300-7995 (2005) [Refereed Article] 
Palmer, AJ and Valentine, WJ and Roze, S and Lammert, M and Spiesser, J and Gabriel, S, Overview of costs of stroke from published, incidence-based studies spanning 16 industrialized countries, Current Medical Research and Opinion, 21, (1) pp. 19-26. ISSN 0300-7995 (2005) [Refereed Article] 
Ray, JA and Valentine, WJ and Secnik, K and Oglesby, AK and Cordony, A and Gordois, A and Davey, P and Palmer, AJ, Review of the cost of diabetes complications in Australia, Canada, France, Germany, Italy and Spain, Current Medical Research and Opinion, 21, (10) pp. 1617-1629. ISSN 0300-7995 (2005) [Refereed Article] 
Minshall, ME and Roze, S and Palmer, AJ and Valentine, WJ and Foos, V and Ray, J and Graham, C, Treating diabetes to accepted standards of care: a 10-year projection of the estimated economic and health impact in patients with type 1 and type 2 diabetes mellitus in the United States, Clinical Therapeutics: The International, Peer-Reviewed Journal of Drug Therapy, 27, (6) pp. 940-950. ISSN 0149-2918 (2005) [Refereed Article] 
Palmer, AJ and Annemans, L and Roze, S and Lamotte, M and Rodby, RA and Bilous, RW, An economic evaluation of the Irbesartan in Diabetic Nephropathy Trial (IDNT) in a UK setting, Journal of Human Hypertension, 18, (10) pp. 733-738. ISSN 0950-9240 (2004) [Refereed Article] 
Palmer, AJ and Roze, S and Lammert, M and Valentine, WJ and Minshall, ME and Nicklasson, L and Gall, MA and Spinas, GA, Comparing the long-term cost-effectiveness of repaglinide plus metformin versus nateglinide plus metformin in type 2 diabetes patients with inadequate glycaemic control: an application of the CORE Diabetes Model in type 2 diabetes, Current Medical Research and Opinion, 20, (Supplement 1) pp. S41-S51. ISSN 0300-7995 (2004) [Refereed Article] 
Palmer, AJ and Roze, S and Valentine, WJ and Smith, I and Wittrup-Jensen, KU, Cost-effectiveness of detemir-based basal/bolus therapy versus NPH-based basal/bolus therapy for type 1 diabetes in a UK setting: an economic analysis based on meta-analysis results of four clinical trials, Current Medical Research and Opinion, 20, (11) pp. 1729-1746 . ISSN 0300-7995 (2004) [Refereed Article] 
Palmer, AJ and Annemans, L and Roze, S and Lamotte, M and Lapuerta, P and Chen, R and Gabriel, S and Carita, P and Rodby, RA and De Zeeuw, D and Parving, HH, Cost-Effectiveness of Early Irbesartan Treatment Versus Control (Standard Antihypertensive Medications Excluding ACE Inhibitors, Other Angiotensin-2 Receptor Antagonists, and Dihydropyridine Calcium Channel Blockers) or Late Irbesartan Treatment in Patients With Type 2 Diabetes, Hypertension, and Renal Disease, Diabetes Care, 27, (8) pp. 1897-1903. ISSN 0149-5992 (2004) [Refereed Article] 
Palmer, AJ and Annemans, L and Roze, S and Lamotte, A and Rodby, RA and de Alvaro, F, Cost-effectiveness of Ibersartan in type II diabetic nephropathy with hypertension. A Spanish perspective, Nefrologia, 24, (3) pp. 231-238. ISSN 0211-6995 (2004) [Refereed Article] 
Palmer, AJ and Roze, S and Valentine, WJ and Minshall, ME and Lammert, M and Nicklasson, L and Spinas, GA, Deleterious effects of increased body weight associated with intensive insulin therapy for type 1 diabetes: increased blood pressure and worsened lipid profile partially negate improvements in life expectancy, Current Medical Research and Opinion, 20, (Supplement 1) pp. S67-S73. ISSN 0300-7995 (2004) [Refereed Article] 
Bergemann, R and Brown, J and Chan, W and Clarke, P and Eddy, D and Herman, W and Palmer, AJ and Roze, S and Stevens, R and Zhang, P, American Diabetes Association Consensus Panel, Guidelines for computer modeling of diabetes and its complications, Diabetes Care, 27, (9) pp. 2262-2265. ISSN 0149-5992 (2004) [Refereed Article] 
Palmer, AJ and Annemans, L and Roze, S and Lamotte, M and Rodby, RA and Ritz, E, Collaborative Study Group, Health economic consequences of irbesartan treatment of type 2 diabetes patients with nephropathy and hypertension in German, Deutsche Medizinische Wochenschrift, 129, (1-2) pp. 13-18. ISSN 0012-0472 (2004) [Refereed Article] 
Palmer, AJ and Rodby, RA, Health economics studies assessing irbesartan use in patients with hypertension, type 2 diabetes, and microalbuminuria, Kidney International. Supplement , (92) pp. S118-S120. ISSN 0098-6577 (2004) [Refereed Article] 
Palmer, AJ and Roze, S and Valentine, WJ and Minshall, ME and Hayes, C and Oglesby, A and Spinas, GA, Impact of changes in HbA1c, lipids and blood pressure on long-term outcomes in type 2 diabetes patients: an analysis using the CORE Diabetes Model, Current Medical Research and Opinion, 20, (1) pp. S53-S58. ISSN 0300-7995 (2004) [Refereed Article] 
Palmer, AJ and Roze, S and Valentine, WJ and Spinas, GA and Shaw, JE and Zimmet, PZ, Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom, Clinical Therapeutics: The International, Peer-Reviewed Journal of Drug Therapy, 26, (2) pp. 304-321. ISSN 0149-2918 (2004) [Refereed Article] 
Segal, L and Dunt, D and Day, SE and Day, NA and Robertson, IK and Hawthorn, G, Introducing co-ordinated care (1): a randomised trial assessing client and cost outcomes, Health Policy, 69, (2) pp. 201-213. ISSN 0168-8510 (2004) [Refereed Article] 
Palmer, AJ and Roze, S and Valentine, WJ and Minshall, ME and Foos, V and Lurati, FM and Lammert, M and Spinas, GA, The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making, Current Medical Research and Opinion, 20, (Supplement 1) pp. S5-S26. ISSN 0300-7995 (2004) [Refereed Article] 
Palmer, AJ and Roze, S and Valentine, WJ and Spinas, G, The cost-effectiveness of continuous subcutaneous insulin infusion compared with multiple daily injections for the management of diabetes: response to Scuffham [corrected] and Carr, Diabetic Medicine, 21, (12) pp. 1372-1372. ISSN 0742-3071 (2004) [Letter or Note in Journal] 
Palmer, AJ and Roze, S and Valentine, WJ and Minshall, ME and Foos, V and Lurati, FM and Lammert, M and Spinas, GA, Validation of the CORE Diabetes Model against epidemiological and clinical studies, Current Medical Research and Opinion, 20, (Supplement 1) pp. S27-S40. ISSN 0300-7995 (2004) [Refereed Article] 
Palmer, AJ and Roze, S and Valentine, WJ and Minshall, ME and Lammert, M and Oglesby, A and Hayes, C and Spinas, GA, What impact would pancreatic beta-cell preservation have on life expectancy, quality-adjusted life expectancy and costs of complications in patients with type 2 diabetes? A projection using the CORE Diabetes Model, Current Medical Research and Opinion, 20, (1) pp. S59-S66. ISSN 0300-7995 (2004) [Refereed Article] 
Roze, S and Palmer, AJ and Valentine, WJ, A multivariate logistic regression equation to screen for diabetes: response to Tabaei and Herman, Diabetes Care, 26, (5) pp. 1658-1659. ISSN 0149-5992 (2003) [Letter or Note in Journal] 
Palmer, AJ and Annemans, L and Roze, S and Lamotte, M and Rodby, RA and Cordonnier, DJ, An Economic Evaluation of Irbesartan in the Treatment of Patients with Type 2 Diabetes, Hypertension and Nephropathy: Cost-Effectiveness of Irbesartan in Diabetic Nephropathy Trial (IDNT) in the Belgian and French Settings, Nephrology, Dialysis and Transplantation, 18, (10) pp. 2059-2066. ISSN 0931-0509 (2003) [Refereed Article] 
Rodby, RA and Chiou, CF and Borenstein, J and Smitten, A and Sengupta, N and Palmer, AJ and Roze, S and Armemans, L and Simon, TA and Chen, RS and Lewis, EJ, Collaborative Study Group, The cost-effectiveness of irbesartan in the treatment of hypertensive patients with type 2 diabetic nephropathy, Clinical Therapeutics: The International, Peer-Reviewed Journal of Drug Therapy, 25, (7) pp. 2102-2119 . ISSN 0149-2918 (2003) [Refereed Article] 
Sendi, P and Palmer, AJ and Hauri, P and Craig, BA and Horber, FF, Modeling the impact of adjustable gastric banding on survival in patients with morbid obesity, Obesity Research, 10, (4) pp. 291-295. ISSN 1071-7323 (2002) [Refereed Article] 
Palmer, AJ, Commentary: Intensive glucose control is more costly than conventional treatment but also has more benefits for people with type-2 diabetes, Evidence - Based Healthcare and Public Health, 5, (1) pp. 17-18. ISSN 1744-2249 (2001) [Contribution to Refereed Journal] 
Gozzoli, V and Palmer, AJ and Brandt, A and Spinas, GA, Economic and clinical impact of alternative disease management strategies for secondary prevention in type 2 diabetes in the Swiss setting , Swiss Medical Weekly, 131, (21-22) pp. 303-310. ISSN 1424-7860 (2001) [Refereed Article] 
Sendi, P and Palmer, AJ and Gafni, A and Battegay, M, Highly Active Antiretroviral Therapy: Pharmacoeconomic issues in the management of HIV infection, Pharmacoeconomics, 19, (7) pp. 709-713. ISSN 1170-7690 (2001) [Refereed Article] 
Gozzoli, V and Palmer, AJ and Brandt, A and Weiss, C and Piehlmeier, W and Landgraf, R and Renner, R, Increased clinical and economic advantage of proteinuric screening and intervention (PROSIT project) in type 2 diabetics, Deutsche Medizinische Wochenschrift, 125, (39) pp. 1154-1159. ISSN 0012-0472 (2001) [Refereed Article] 
Palmer, AJ and Sendi, PP, New aspects in health economic studies of prevention and treatment of osteoporosis, Expert Review of Pharmacoeconomics & Outcomes Research, 1, (2) pp. 198-204. ISSN 1744-8379 (2001) [Refereed Article] 
Palmer, AJ and Sendi, PP and Spinas, GA, Applying some UK Prospective Diabetes Study results to Switzerland: The cost-effectiveness of intensive glycemic control with metformin versus conventional control in overweight patients with type 2 diabetes, Schweizerische Medizinische Wochenschrift, 130, (27-28) pp. 1034-1040. ISSN 0036-7672 (2000) [Refereed Article] 
Robertson, IK and Richardson, J, Coronary angiography and coronary artery revascularisation rates in public and private hospital patients after acute myocardial infarction, Medical Journal of Australia, 173, (6) pp. 291-295. ISSN 0025-729X (2000) [Refereed Article] 
Sendi, P and Palmer, AJ, Modeling the socioeconomic impact of osteoporosis-related hip fractures in Switzerland, Osteoporosis International, 11, (1) pp. 92-94 . ISSN 0937-941X (2000) [Refereed Article] 
Palmer, AJ and Brandt, A and Gozzoli, V and Weiss, C and Stock, H and Wenzel, H, Outline of a diabetes disease management model: principles and applications, Diabetes Research and Clinical Practice, 50, (Supplement 3) pp. S47-S56. ISSN 0168-8227 (2000) [Refereed Article] 
Palmer, AJ and Weiss, C and Sendi, PP and Neeser, K and Brandt, A and Singh, G and Wenzel, H and Spinas, GA, The cost-effectiveness of different management strategies for type I diabetes: a Swiss perspective, Diabetologia: Clinical and Experimental Diabetes and Metabolism, 43, (1) pp. 13-26. ISSN 0012-186X (2000) [Refereed Article] 
Palmer, AJ and Neeser, K and Weiss, C and Brandt, A and Comte, S and Fox, M, The long-term cost-effectiveness of improving alcohol abstinence with adjuvant acamprosate, Alcohol and Alcoholism, 35, (5) pp. 478-492. ISSN 0735-0414 (2000) [Refereed Article] 
Brown, JB and Palmer, AJ and Bisgaard, P and Chan, W and Pedula, K and Russell, A, The Mt. Hood Challenge: cross-testing two diabetes simulation models, Diabetes Research and Clinical Practice, 50, (Supplement 3) pp. S57-S64. ISSN 0168-8227 (2000) [Refereed Article] 
Palmer, AJ and Sendi, PP, Meta-analysis in oral health care, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, 87, (2) pp. 135-141. ISSN 1079-2104 (1999) [Refereed Article] 
Sendi, PP and Palmer, AJ and Marinello, CP, Some principles of cost-effectiveness analysis in dentistry, Acta Medicinae Dentium Helvetica, 4, (4) pp. 63-67. ISSN 1420-8873 (1999) [Refereed Article] 
Palmer, AJ and Neeser, K and Paschen, B and Cleland, JGF, Economic implications of the Total Ischemic Burden Bisoprolol Study (TIBBS) follow-up, Journal of Medical Economics , 1, (1-4) pp. 263-280. ISSN 1941-837X (1998) [Refereed Article] 
Neeser, K and Brandt, A and Palmer, AJ and Volz, A, Gesundheitsoekonomische Auswirkungen der Algodystrophie unter Einbezug von Calcitonin [Health economic effects of calcitonin on algodystrophy], Managed Care (Switzerland), 1, (6) pp. 39-43. ISSN 1422-6618 (1998) [Refereed Article] 
Palmer, AJ and Koppenhagen, K and Kirchhof, B and Weber, U and Bergemann, R, Efficacy and safety of low molecular weight heparin, unfractionated heparin and warfarin for thromboembolism prophylaxis in orthopaedic surgery: A meta-analysis of randomised clinical trials, Haemostasis, 27, (2) pp. 75-84. ISSN 0301-0147 (1997) [Refereed Article] 
Sendi, PP and Palmer, AJ and Marinello, CP, Health State Utilities in Dentistry: A Review, Acta Medicinae Dentium Helvetica, 2, (10) pp. 243-248. ISSN 1420-8873 (1997) [Refereed Article] 
Palmer, AJ and Schramm, W and Kirchhof, B and Bergemann, R, Low Molecular Weight Heparin for Prevention of Thromboembolism in General Surgery: A Meta-Analysis of Randomized Clinical Trials with Low Molecular Weight Heparin, Unfractionated Heparin, and Warfarin, Haemostasis, 27, (2) pp. 65-74. ISSN 0301-0147 (1997) [Refereed Article] 
Palmer, AJ and Brandt, A, The cost-effectiveness of gemcitabine plus cisplatin chemotherapy versus mitomycin ifosfamide and cisplatin (MIP), etopiside plus cisplatin, and vinorelbine plus cisplatin in the treatment of stages III B and IV non-small cell lung cancer: An Italian perspective (letter), Monaldi Archives for Chest Disease, 52, (3) pp. 305-306. ISSN 1122-0643 (1997) [Letter or Note in Journal] 
Kirchhof, B and Palmer, AJ and Kakkar, VV and Bergemann, R, The Economic Burden of Deep Vein Thrombosis Sequelae: A Cost of Illness Analysis for Germany, Gesundheitsoekonomie und Qualitaetsmanagement , 2 pp. 40-44. ISSN 1439-4049 (1997) [Refereed Article] 
Palmer, AJ and Brandt, A, The cost-effectiveness of gemcitabine plus cisplatin chemotherapy versus mitomycin ifosfamide and cisplatin (MIP), etopiside plus cisplatin, and vinorelbine plus cisplatin in the treatment of stages III B and IV non-small cell lung cancer: An Italian perspective, Monaldi Archives for Chest Disease, 51, (4) pp. 279-288. ISSN 1122-0643 (1996) [Refereed Article] 
Book
Richardson, J and Robertson, IK and Hobbs, M and Edwards, D, The impact of new technology on the treatment and outcomes of acute myocardial infarction in Australia: Incentives for technological change and their consequences for treatment decision making, Univeristy of Michigan Press, Michigan USA, pp. 30. ISBN 0472111280 (2003) [Authored Research Book] 
Chapter in Book
Zaidi, STR and Babar, Z-U-D, Applying Pharmacoeconomics in Community and Hospital Pharmacy Research, Pharmacy Practice Research Methods, Springer, Z-U-D Babar (ed), Switzerland, pp. 157-173. ISBN 978-3-319-14671-3 (2015) [Research Book Chapter] 
Review
Segal, L and Robertson, IK, Out of pocket expenses and use of informal support by Health Services Clients with selected medical conditions, A Report to Commonwealth Department of Health and Ageing, 1, (1) pp. 4. (2002) [Review Single Work] 
Conference Publication
Campbell, JA and Ezzy, D and Neil, A and Hensher, M and Venn, A and Sharman, M and Wilkinson, S and Palmer, AJ, PCP4 A qualitative investigation of information asymmetry for obesity surgery: Diversity of patient experiences in the information age and demand-induced supply, Value in Health, pp. S23, Vol 21. ISSN 1098-3015 (2018) [Conference Extract]
Campbell, JA and Hensher, M and Davies, D and Green, M and Hagan, B and Jordan, I and Venn, A and Kuzminov, A and Neil, A and Palmer, AJ, PSY33 A Cost-Outcome Study: A real-world investigation of long-term inpatient hospital utilisation and costs for a retrospective cohort of bariatric surgery patients in an Australian public hospital system based on Australia's activity based funding model, Value in Health, pp. S111, Vol 21. ISSN 1098-3015 (2018) [Conference Extract]
Campbell, JA and Hensher, M and Venn, A and Neil, A and Otahal, P and Palmer, AJ, PSY15 A unique opportunity to assess quality-of-life changes in long-term waitlisted bariatric surgery patients using the EQ-5D-5L and AQOL-8D multi-attribute utility instruments before and three months after bariatric surgery: an exploratory study, Value in Health, pp. A882, Vol 19. ISSN 1098-3015 (2016) [Conference Extract]
Thesis
Campbell, JA, The Health Economics of Obesity and Bariatric Surgery (2018) [PhD]
Entry
Williams, S, Drugs, Geography of, Encyclopedia of Geography, Warf, B (ed), New Delhi (2010) [Entry] 

This list was generated on Sun Oct 20 13:24:03 2019.